Prohibited substance raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-06-08 and is reviewed periodically as new material appears.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
| Property | Value | Notes |
|---|---|---|
| WADA classification | S4 Hormone and Metabolic Modulators | Prohibited at all times in sport. |
| Drug approval status | Not approved in major jurisdictions | No accepted therapeutic indication. |
| Common detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Typical test matrix | Urine or blood | Urine is common in anti-doping testing. |
| Product labeling | Research chemical or supplement | Often not independently verified. |
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Although sublingual administration of estradiol has a relatively short duration, the medication can be administered multiple times per day in divided doses to compensate for this. Studies that used high doses of sublingual estradiol in the treatment of severe postpartum depression have administered a dose of 1 mg 3 to 8 times per day. In one study, which administered a mean total dosage of sublingual estradiol of 4.8 mg/day, estradiol levels remained elevated at about 130 pg/mL on average in the morning before the first dose of the day. Oral micronized estradiol valerate tablets can be taken sublingually as well. The administration of 2 mg oral micronized estradiol valerate tablets (Progynova, Schering) sublingually 3 or 4 times per day resulted in circulating estradiol levels of about 290 pg/mL to 460 pg/mL in premenopausal women (time of measurements not given). Steady-state levels of estradiol were achieved within about 5 or 6 days. Levels of progesterone, luteinizing hormone, and follicle-stimulating hormone were all considerably suppressed, and ovulation, as well as the associated mid-cycle hormonal surges, were prevented. Sublingual estradiol valerate is used for cycle control in egg donation and surrogacy in cisgender women and is used in hormone therapy for transgender women. Cyclodextrin-containing formulations of sublingual estradiol with improved water solubility and absorption have been developed and studied.
However, the mobilization against the "peace process", as its defenders called it, did not prevent the government from initiating contacts with the ETA leadership. To put pressure on the government, ETA intensified street fighting (kale borroka) and finally on December 30, 2006, T-4 bombing placed a powerful bomb in the T-4 terminal of Barajas airport which caused the death of two people and enormous material damage. The government considered the "peace process" "suspended" and on June 4, ETA announced the end of the truce. Attacks were resumed and members of ETA and Batasuna were arrested. Likewise, the process of illegalization of the Communist Party of the Basque Homelands and Basque Nationalist Action began. In response ETA murdered in cold blood a former socialist councilman in the Gipuzkoan town of Mondragón on the eve of the March 2008 general election.
== Research and career == Okan worked as a research fellow for one year at the Cleveland Clinic, USA. He studied wound care after laser resurfacing. He participated in the clinical and research activities of the Cleveland Clinic Florida Dermatology Department, published several clinical research articles and conducted clinical research projects. His research interest has focused on psoriasis, vitiligo, rosacea, laser and dermatologic signs of systemic diseases and wound healing. In April 2015, Okan published a popular book about dermatology, "Krem-Cilt Sağlığının ABC'si" ("Cream: The ABC's of Skin Care"). The book reflects day-to-day clinical experience and direct knowledge of cutting edge advances, advising people to choose cosmetic products carefully, and to maintain proper nutrition and hydration. He particularly advises parsley, nettle, chamomile, ginseng, thyme, melon, broccoli, and carrot, as well as Vitamin A, Vitamin B3, Vitamin C, Vitamin D, Vitamin K, Vitamin H, zinc and iron. In other media, Okan has also deemed a good-quality sunscreen to be the best defense against aging. Later in 2015, he participated in 23rd World Congress of Dermatology, in Vancouver. Okan is a European Board Certified dermatologist and passed the Specialty Certificate Examination (SCE) in Dermatology in the UK.
Cereulide is a heat-stable toxin produced by some strains of Bacillus cereus, B. megaterium and related species. It is a potent cytotoxin that causes nausea and vomiting. Cereulide acts as an ionophore with a high affinity for potassium cations. Exposure to cereulide causes loss of the membrane potential and uncoupling of oxidative phosphorylation in the mitochondria. The nausea and vomiting is believed to be caused by cereulide's binding and activation of 5-HT3 receptors, leading to increased afferent vagus nerve stimulation. Cereulide is a cyclic dodecadepsipeptide resembling valinomycin; it contains three repeats of four amino acids: D-Oxy-Leu—D-Ala—L-Oxy-Val—L-Val. It is produced by a dedicated non-ribosomal peptide synthesis (NRPS) system in B. cereus. The spores of cereulide-producing strains of B. cereus and related species are manyfold more heat resistant than spores of cereulide non-producers. The toxin has no loss of activity upon autoclaving, cooking, or baking.
Sources: en.wikipedia.org
In the 12th century BCE, many Israelite settlements appeared in the central hill country of Canaan, which was formerly an open terrain. These settlements lacked evidence of pork consumption, compared to Philistine settlements, had four-room houses and lived by an egalitarian ethos, which was exemplified by the absence of elaborate tombs, governor's mansions, certain houses being bigger than others etc. They followed a mixed economy, which prioritized self-sufficiency, cultivation of crops, animal husbandry and small-scale craft production. New technologies such as terraced farming, silos for grain storage and cisterns for rainwater collection were simultaneously introduced. These settlements were built by inhabitants of the "general Southland" (i.e. modern Sinai and the southern parts of Israel and Jordan), who abandoned their pastoral-nomadic ways. Canaanites who lived outside the central hill country were tenuously identified as Danites, Asherites, Zebulunites, Issacharites, Naphtalites and Gadites. These inhabitants do not have a significant history of migration besides the Danites, who allegedly originate from the Sea Peoples, particularly the Dan(an)u. Nonetheless, they intermingled with the former nomads, due to socioeconomic and military factors. Their interest in Yahwism and its concern for the underprivileged was another factor. Possible allusions to this historical reality in the Hebrew Bible include the aforementioned tribes, except for Issachar and Zebulun, descending from Bilhah and Zilpah, who were viewed as "secondary additions" to Israel.
==== Ban ==== Banban Akaza (赤座 伴番, Akaza Banban), also known as "Ban" (バン), is a hot-headed, chaotic, loudmouthed, bad-tempered, yet fiercely loyal and friendly rookie member of the S.P.D., who previously trained in space before being assigned to lead S.P.D.'s Earth unit in the field as Deka Red (デカレッド, Deka Reddo). While he joins the newly created Fire Squad as an elite officer in the series finale, he occasionally returns to help his original team. Initially having an immature personality, he slowly matures throughout the series. In battle, Ban is a practitioner of the space martial art Juu Kune Do (ジュウクンドー, Jū Kun Dō), which blends unarmed martial arts skills with gunplay. As Deka Red, he dual wields a pair of D-Magnum (ディーマグナム, Dī Magunamu) rayguns, which can combine to form the Hybrid Magnum (ハイブリッドマグナム, Haiburiddo Magunamu) shotgun and allow him to perform the Magnum Execution (マグナムエクスキュージョン, Magunamu Ekusukyūjon), Moonsault Shot (ムーンサルトショット, Mūnsaruto Shotto), Endless Shot (エンドレスショット, Endoresu Shotto), Hurricane Shot (ハリケーンショット, Harikēn Shotto), and Moonsault Galaxy Shot (ムーンサルトギャラクシーショット, Mūnsaruto Gyarakushī Shotto) attacks. He also shares riding the Machine Doberman (マシンドーベルマン, Mashin Dōberuman) police car with Jasmine. If necessary, he can borrow Doggie Kruger's D-Sword Vega to perform the Akaza Sword Art: Raijin Sword (赤座剣法・雷神剣, Akaza Kenpō Raijin Ken) and Impulse Vega Slash (インパルスベガスラッシュ, Inparusu Bega Surasshu) attacks. During the events of the crossover film Mahō Sentai Magiranger vs.
== Background == By the mid-1790s, Humboldt had devoted himself wholly to scientific investigations. Despite being offered a promotion and an increase in pay, he resigned his position as a mining official in the Prussian civil service in order to embark on a journey that would “advance him scientifically.” To the Minister of Mines in Berlin Humboldt declared: "I am considering a complete change in my mode of life, and I intend to withdraw from any official position with the state." His health, he claimed, had suffered. All he had wanted was to prepare himself for a scientific expedition by a practical employment in the mines. "As I have a deep conviction that such an expedition is highly important for increasing our knowledge of geology and physical science, I am exceedingly eager to devote my energies immediately to this end. After his mother's death in 1796, Humboldt inherited the financial means to pursue independent explorations. He decided to go to Italy, where he wanted to spend a year to a year and a half researching volcanoes. From there, he wanted to travel via Paris to England, where he would board a ship to the West Indies. However, the political instability caused by Napoleon's Italian campaign in 1797 forced Humboldt to cancel his plans. In May 1798, Humboldt traveled to Paris, where he met the botanist Aimé Bonpland. After their attempt to travel to Egypt had once again failed due to Napoleon and his campaign there, the two decided to go to Madrid in December 1798.
Sources: en.wikipedia.org
Marxism–Leninism–Maoism–Prachanda Path (Nepali: मालेमावाद र प्रचण्डपथ Mālemāvād ra Prachaṇḍapath; sometimes shortened to Prachanda Path) is the ideological line of the Communist Party of Nepal (Maoist Centre), also known as the CPN (MC). It is considered a development of Marxism–Leninism–Maoism (MLM) and named after the leader of the CPN (MC), Pushpa Kamal Dahal, commonly known as Prachanda. Prachanda Path was proclaimed in 2001. The ideology was partially inspired by the example of the Communist Party of Peru – Shining Path, which refers to its ideological line as Marxism–Leninism–Maoism–Gonzalo Thought. Prachanda Path does not claim to make an ideological break with Marxism, Leninism or Maoism, but rather to be an extension of these ideologies based on the politics of Nepal. The doctrine came into existence after the party determined that the ideologies of Marxism, Leninism and Maoism could no longer be practiced completely as they had been in the past. The party adopted Prachanda Path as they felt it was a suitable ideology based on the reality of Nepalese politics. Militarily and in the context of the 1996–2006 civil war in Nepal, central to the ideology was the achievement of revolution through the control of rural areas and the encirclement of urban settlements. The CPN (MC) was seen to have abandoned Maoism in its decision to merge with the Communist Party of Nepal (Unified Marxist–Leninist) to form the Nepal Communist Party, but this party has since been disestablished and the CPN (MC) reconstituted.
== Qualifications == The Constitution of Myanmar sets the principle qualifications that the candidate must meet to be eligible for the office of the President. in Chapter 1: The President, Part I: The Federation of Myanmar in the Constitution of Myanmar. President has to be:
The delay in effectiveness of the incapacitation mechanism is believed to be a protective mechanism that prevents a male fly from incapacitating his own sperm should he mate with the same female fly repetitively. Sensory neurons in the uterus of female D. melanogaster respond to a male protein, sex peptide, which is found in semen. This protein makes the female reluctant to copulate for about 10 days after insemination. The signal pathway leading to this change in behavior has been determined. The signal is sent to a brain region that is a homolog of the hypothalamus and the hypothalamus then controls sexual behavior and desire. Gonadotropic hormones in Drosophila maintain homeostasis and govern reproductive output via a cyclic interrelationship, not unlike the mammalian estrous cycle. Sex peptide perturbs this homeostasis and dramatically shifts the endocrine state of the female by inciting juvenile hormone synthesis in the corpus allatum. D. melanogaster is often used for life extension studies, such as to identify genes purported to increase lifespan when mutated. D. melanogaster is also used in studies of aging. Werner syndrome is a condition in humans characterized by accelerated aging. It is caused by mutations in the gene WRN that encodes a protein with essential roles in repair of DNA damage. Mutations in the D. melanogaster homolog of WRN also cause increased physiologic signs of aging, such as shorter lifespan, higher tumor incidence, muscle degeneration, reduced climbing ability, altered behavior and reduced locomotor activity.
Professor for addiction research Heino Stöver notes that the shops can be seen as a political statement, advancing drug legalization "from below". The results of these markets are higher quality and lower prices of psychoactive substances as well as a lower risk of violent incidents. A number of studies suggest that markets such as Silk Road may have helped users reduce the harm caused by illicit drug use, particularly compared with street-based drug marketplaces. Examples include the sale of high-quality products with low risk for contamination (including lacing and cutting), vendor-tested products, sharing of trip reports, and online discussion of harm reduction practices. Some health professionals such as "DoctorX" provide information, advice and drug-testing services on the darknet. The quality of products is attributed to the competition and transparency of darknet markets which involve user feedback and reputation features. Europol reported in December 2014, "We have lately seen a large amount of physical crime move online, at least the 'marketing' and delivery part of the business ... [Buyers can] get the illegal commodity delivered risk-free to a place of their choice by the mailman or a courier, or maybe by drone in the future, and can pay with virtual currency and in full anonymity, without the police being able to identify either the buyer or the seller." In June 2015 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) produced a report citing difficulties controlling virtual market places via darknet markets, social media and mobile apps.
Sources: en.wikipedia.org
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.
Legality varies by country and context. It lacks marketing approval as a medicine in major countries. Sports organizations prohibit its use at all times.
A certificate of analysis may report identity, purity, and testing methods for a specific batch. It does not guarantee safety or legal status. Independent verification can confirm whether the material matches the label.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.